Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease Research.

[1]  J. Moul,et al.  Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. , 2002, Radiology.

[2]  R. Riffenburgh,et al.  20-year outcome of patients with T1-3N0 surgically staged prostate cancer treated with external beam radiation therapy. , 2001, The Journal of urology.

[3]  J. Moul,et al.  Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. , 2000, The Journal of urology.

[4]  P. Johnstone,et al.  Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. , 2000, International journal of radiation oncology, biology, physics.

[5]  R. Riffenburgh,et al.  Outcome for surgically staged localized prostate cancer treated with external beam radiation therapy. , 1997, The Journal of urology.

[6]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[7]  R. Riffenburgh,et al.  Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[8]  A. Partin,et al.  Radical prostatectomy in men less than 50 years old. , 1995, Urologic oncology.

[9]  Zuo-Feng Zhang,et al.  Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients , 1994, Cancer.

[10]  K. Convery,et al.  Age‐race Interaction in Prostatic Adenocarcinoma Treated with External Beam Irradiation , 1993, American journal of clinical oncology.

[11]  R. Gittes Carcinoma of the prostate. , 1991, The New England journal of medicine.

[12]  M. Benson,et al.  Prostate cancer in men less than 45 years old: influence of stage, grade and therapy. , 1987, The Journal of urology.

[13]  G. Harrison The prognosis of prostatic cancer in the younger man. , 1983, British journal of urology.

[14]  G. Murphy,et al.  Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey. , 1982, Urology.

[15]  I. Silber,et al.  Adenocarcinoma of the prostate in men less than 56 years old: a study of 65 cases. , 1971, The Journal of urology.

[16]  F. Mostofi,et al.  Cancer of the prostate in men less than 50 years old: an analysis of 51 cases. , 1969, The Journal of urology.

[17]  F. R. Watson,et al.  A comparison by age of death rates due to prostate cancer alone. , 1968, The Journal of urology.

[18]  S. Rosenberg IS CARCINOMA OF THE PROSTATE LESS SERIOUS IN OLDER MEN? , 1965, Journal of the American Geriatrics Society.

[19]  D. Culp,et al.  CLINICAL ADENOCARCINOMA OF THE PROSTATE IN PATIENTS UNDER 50 YEARS OF AGE. , 1965, The Journal of urology.

[20]  E. Gehan,et al.  Carcinoma of the Prostate: A Continuing Co-Operative Study* , 1964 .

[21]  W. Whitmore The rationale and results of ablative surgery for prostatic cancer , 1963, Cancer.

[22]  A. Partin,et al.  Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. , 1999, Urology.

[23]  E. Leifer,et al.  Prostate-specific antigen to predict outcome of external beam radiation for prostate cancer: Walter Reed Army Medical Center experience, 1988-1995. , 1999, Urology.

[24]  H. Zincke,et al.  Radical retropubic prostatectomy for prostate cancer in the elderly and the young: complications and prognosis. , 1994, European urology.

[25]  O. Khanna,et al.  Carcinoma of prostate in men aged fifty and under: therapeutic options. , 1992, Urology.

[26]  D. Johnson,et al.  Prostatic adenocarcinoma occurring in men under 50 years of age , 1972, Journal of surgical oncology.